<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is the leading cause of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Aside from <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo>, other metabolic factors may determine renal outcome </plain></SENT>
<SENT sid="2" pm="."><plain>We examined risk associations of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> with new <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) in 5,829 Chinese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> enrolled between 1995 and 2005 </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> was defined by National Cholesterol Education Program Adult Treatment Panel III criteria with the Asian definition of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Renal Disease</z:e> formula modified for the Chinese population </plain></SENT>
<SENT sid="5" pm="."><plain>New <z:hpo ids='HP_0003674'>onset</z:hpo> of CKD was defined as eGFR &lt;60 ml/min per 1.73 m(2) at the time of censor </plain></SENT>
<SENT sid="6" pm="."><plain>Subjects with CKD at baseline were excluded from the analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: After a median follow-up duration of 4.6 years (interquartile range: 1.9-7.3 years), 741 patients developed CKD </plain></SENT>
<SENT sid="8" pm="."><plain>The multivariable-adjusted hazard ratio (HR) of CKD was 1.31 (95% CI 1.12-1.54, P = 0.001) for subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> compared with those without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Relative to subjects with no other components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> except for <z:mp ids='MP_0002055'>diabetes</z:mp>, those with two, three, four, and five <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components had HRs of an increased risk of CKD of 1.15 (0.83-1.60, P = 0.407) 1.32 (0.94-1.86, P = 0.112), 1.64 (1.17-2.32, P = 0.004), and 2.34 (1.54-3.54, P &lt; 0.001), respectively </plain></SENT>
<SENT sid="10" pm="."><plain>The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> traits of central <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and low BMI were independent predictors for CKD </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The presence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> independently predicts the development of CKD in subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>